Search Results for Michael Diem (Corporate Dealmaker)

Sunday, November 22,

3:43 pm

  • Log in to The Deal Pipeline
  • Subscribe to The Deal magazine
  • Products & services

Corporate Dealmaker: Helping companies succeed in the deal economy.

Syndicate

Subscribe to our RSS feed

Contributors

Search Results

Advanced Search

Sort ByDate Relevance	Search InCorporate Dealmaker The entire Deal Blogs Network

1 result(s) displayed (1 - 1 of 1):

Glaxo, Novartis, Roche, Lilly back same company (from Corporate Dealmaker)

In an interesting play, four rival drug giants are using their venture capital arms to back a company they think has come up with a major new class of therapeutics. Biotech company Aileron Therapeutics received financing from GlaxoSmithKline plc (NYSE:GSK), Novartis AG (NYSE:NVS), Roche Holding AG (SWX:ROG) and Eli Lilly...

Posted on June 8, 2009 3:30 PM

Movable Type search results powered by Fast Search

Search

Corporate Dealmaker Video

Deal Economy 2010: Avaya's Ali on digesting Nortel

Avaya Inc.'s Mohamad Ali on the company's next target.

Movers & Shakers

Juergen Lasowski
Onyx Pharmaceuticals Inc.

Edward Swallow
Northrop Grumman Corp.

Owen Mahoney
Outspark

Alice Kim
FLO TV Inc.

Eric Hausler
Isle of Capri Casinos Inc.

Juergen Lasowski, Onyx Pharmaceuticals Inc.

Edward Swallow, Northrop Grumman Corp.

Owen Mahoney, Outspark

Alice Kim, FLO TV Inc.

Eric Hausler, Isle of Capri Casinos Inc.

COMPLETE MOVERS & SHAKERS ARCHIVES

The Magazine

And the winners are...

Even in a period when things like toxic credit default swaps and noxious structured investment vehicles dominate the conversation in many parts of the deal community, people are still willing to take the time to recognize skill and achievement in the strategic transactions that help those companies adapt and grow.
View the complete issue